Champions Oncology, Inc.
CSBR
$7.49
-$0.68-8.32%
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 166.07% | 93.79% | 55.20% | -36.38% | -211.99% |
| Total Depreciation and Amortization | -7.14% | 0.85% | 10.71% | 15.53% | -4.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -48.87% |
| Total Other Non-Cash Items | -34.82% | -22.92% | -15.07% | 9.83% | 51.80% |
| Change in Net Operating Assets | -1,923.60% | -425.38% | -226.20% | -190.10% | -113.69% |
| Cash from Operations | 74.11% | -7.38% | -1,142.61% | -254.51% | -191.81% |
| Capital Expenditure | 98.44% | 96.68% | 97.85% | 74.65% | 38.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 98.44% | 96.68% | 97.85% | 74.65% | 38.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -138.89% | -243.24% | -- | -- | -- |
| Issuance of Common Stock | 25.00% | 9.92% | 145.92% | 194.19% | 147.06% |
| Repurchase of Common Stock | 100.00% | 100.00% | 95.27% | -745.33% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 110.09% | 104.33% | 85.84% | -5,872.73% | -653.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 82.36% | 48.07% | 38.01% | -775.07% | -343.78% |
